POSTER: MDS-569 Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients With Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region

Clinical Lymphoma Myeloma and Leukemia(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要